ReBuilder Medical: Company Information
ReBuilder Medical Technologies, Inc. has been successfully inventing, developing, manufacturing, and distributing medical devices for well over 10 years, via the internet. The company is now expanding its marketing to reach beyond the internet, to include physician's offices, radio and TV.
The company is performing research and development on several new devices; see the section below entitled Our Future.
The company is headed by CEO David B. Phillips, Ph.D., an internationally recognized electronic medical device inventor who holds many patents, and received the Inventor of the Year Award in 1986 for the Infrared Ear Thermometer (FirsTemp) that is the standard for taking the body's core temperature all over the world. Dr. Phillips is also well known for his inventions such as the Phillips Molluscum Treatment System, for treatment of Molluscum Contagiosum, the GST System for Early Breast Cancer Detection, as well as other medical innovations. Dr. Phillips is a faculty member and an instructor at the American College of Physical Medicine in Chicago, and Editor-in-Chief of their journal. He co-authored the sylabus for training in Neuropathy.
ReBuilder Medical Inc. is a multi-disciplinary medical device company specializing in chronic intractable pain treatment, molluscum and diabetes.
ReBuilder Medical Technologies, Inc. began business with the ReBuilder® as Micro Med, Inc. of Vermont in 1985. We began manufacturing ReBuilders in 1987 (after 2 years R&D) when the device was first introduced to help Dr. Phillips' father recover from open heart coronary bypass surgery. His father complained more from the leg incision (to remove the greater saphenous vein for grafting material) than from the chest incision. The ReBuilder® was successfully registered with the FDA in 1987 in two categories, TENS and EMS separately, under the 510K registration process. MicroMed was merged into ReBuilder Medical, Inc. in 2001. Dr. Phillips continues as the official FDA correspondent.
The ReBuilder® has undergone many improvements and versions over the years and was enhanced to help peripheral artery disease in 1995. In 2001, when we reorganized, and moved the company to West Virginia, we optimized the ReBuilder® to help patients with intractable pain when previous users reported that they had loaned their units to diabetic patients with neuropathic pain and it had helped them. When we discovered how many people suffer from peripheral neuropathy, we redirected our focus to solving the mystery of peripheral neuropathy and providing relief for their pain. The current 2407 model incorporates the latest technology. The ReBuilder® has a patent application pending (10/823,774) for its unique waveform that merges TENS and EMS with an exact copy of a healthy nerve signal.
Twenty million, eight hundred thousand children and adults, or 7% of the U.S. population suffer from diabetes. Thirty percent of those diagnosed with diabetes will eventually suffer from pain and numbness in the feet and hands that can lead to complete loss of mobility, gangrene, and eventual amputations. $132 Billion per year is the current cost of treatment for diabetes, or 1 of every 10 health care dollars spent. Pain sufferers constitute 33% of this market, or 43.56 billion dollars in potential market. ReBuilder Medical, Inc. is a company in its infancy that has targeted 10% of this market. Its only competition is from drug companies.
We are performing R&D to finalize an electronic allergy detection system and another to offer a pocket sized instrument to make it easier for a nurse to draw blood samples, tentatively named "Vein-Appear". We are also working on development of a unique view box for xrays which would allow the physician to see much more detail that current solutions offer and a simply designed sling vest for arm injuries that provides improved comfort to the wearer as well as preventing secondary complications.
The company operates from a 10,000 square foot facility that it has rented long term since 2002. This facility has been remodeled twice and enlarged once to accommodate ever increasing sales. The company is seeking additional manufacturing space now to accommodate the continuing and expected sales increases.